Moneycontrol
SENSEX NIFTY
YOU ARE HERE >  Moneycontrol Markets > Announcements Pharmaceuticals

Vivanza Biosciences

BSE: 530057|ISIN: INE984E01027|SECTOR: Pharmaceuticals
SET ALERT
|
ADD TO PORTFOLIO
|
WATCHLIST
LIVE
BSE
Feb 16, 16:00
72.00
0
VOLUME 15
Vivanza Biosciences is not listed on NSE
Announcements on Vivanza Bio

25th-Jan-2018 17:06Source: BSE

Vivanza Biosciences- Newspaper Publication

Copy of Newspaper Advertisement of Unaudited Standalone and Consolidated Financial Results for the Quarter ended on December 31, 2017 as per the Regulation 47(1)(b) and 47(3) of the (Listing Obligatio...

23rd-Jan-2018 16:48Source: BSE

Vivanza Biosciences- Financial Results For December 31, 2017.

Considered and approved the Unaudited Standalone and Consolidated Financial Results for the Quarter ended December 31, 2017 along with Limited Review report thereon as per Regulation 33 of Securities ...

20th-Jan-2018 16:35Source: BSE

Vivanza Biosciences- Shareholding for the Period Ended December 31, 2017

Vivanza Biosciences Ltd has submitted to BSE the Shareholding Pattern for the Period Ended December 31, 2017. For more details, kindly

12th-Jan-2018 15:35Source: BSE

Vivanza Biosciences- Statement Of Investor Complaint For The Quarter Ended December 31, 2017.

Quarterly Statement of Investor Complaint pursuant to Regulation 13 (3) of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 for the quarter ended 31st December, 2017.

18th-Dec-2017 16:23Source: BSE

Vivanza Biosciences- Newspaper Publication

Copy of Newspaper Advertisement of Unaudited Standalone and Consolidated Financial Results for the Quarter ended on September 30, 2017

14th-Dec-2017 17:13Source: BSE

Vivanza Biosciences- Financial Results For September 30, 2017.

Outcome of meeting of Board of Directors of the Company held on 14th December, 2017.

5th-Dec-2017 17:05Source: BSE

Vivanza Biosciences- Board Meeting On December 14, 2017.

Intimation of Board Meeting and Closure of Trading Window

11th-Nov-2017 15:40Source: BSE

Vivanza Biosciences- Updates

Opting for submission and publication of Unaudited Standalone and Consolidated Financial Results for the Quarter ended 30th September, 2017, during the extended period of 30 days.

27th-Oct-2017 17:13Source: BSE

Vivanza Biosciences- Certificate Under Regulation 40 (9) For The Half Year Ended On 30/09/2017.

Certificate under Regulation 40 (9) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 for the half year ended on 30/09/2017.

18th-Oct-2017 13:55Source: BSE

Vivanza Biosciences- Shareholding for the Period Ended September 30, 2017

Vivanza Biosciences Ltd has submitted to BSE the Shareholding Pattern for the Period Ended September 30, 2017. For more details, kindly

Quick Links for Vivanza Biosciences
Explore Moneycontrol
Stocks     A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W | X | Y | Z | Others
Mutual Funds     A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W | X | Y | Z
Copyright © e-Eighteen.com Ltd. All rights reserved. Reproduction of news articles, photos, videos or any other content in whole or in part in any form or medium without express written permission of moneycontrol.com is prohibited.